Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹1,383 Cr
up ₹72 Cr vs May 2021
- Stocks held
- 25
- unchanged
- Top 10 weight
- 63.5%
- of the portfolio in its ten largest
- Cash & debt
- 2.9%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 4
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In June 2021 it disclosed 25 stocks worth ₹1,383 Cr, up ₹72 Cr from May 2021. Its largest positions were Sun Pharmaceutical Industries Limited (9.4%), Cipla Limited (8.5%), Lupin Limited (6.9%); the ten largest together made up 63.5% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 62.2% of its equity. Cash and debt stood at 2.9%. Compared with May 2021 the fund entered 0 new stocks and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
88%
Top-10 weight is higher than 88% of peers
Breadth
8%
Holds more stocks than 8% of peers
Cash
40%
Holds more cash than 40% of peers
What these mean: concentration · cash
Holdings in June 2021
Download CSVEvery line the fund disclosed, with the change against May 2021. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 9.42% | up 0.63 pts | ₹130 Cr | up ₹15 Cr | Added |
| Cipla Limited | 8.55% | down 0.26 pts | ₹118 Cr | up ₹2.7 Cr | Added |
| Lupin Limited | 6.94% | down 0.83 pts | ₹96 Cr | down ₹5.9 Cr | Trimmed |
| Dr. Reddy's Laboratories Limited | 6.57% | down 0.22 pts | ₹90.8 Cr | up ₹1.9 Cr | Added |
| IPCA Laboratories Limited | 5.79% | down 0.45 pts | ₹80 Cr | down ₹1.7 Cr | Trimmed |
| Procter & Gamble Health Limited | 5.76% | up 0.76 pts | ₹79.7 Cr | up ₹14.2 Cr | Added |
| Max Healthcare Institute Limited | 5.70% | up 0.44 pts | ₹78.7 Cr | up ₹9.9 Cr | Added |
| Apollo Hospitals Enterprise Limited | 5.51% | up 0.42 pts | ₹76.2 Cr | up ₹9.5 Cr | Added |
| Divi's Laboratories Limited | 5.36% | down 0.02 pts | ₹74.1 Cr | up ₹3.6 Cr | Added |
| Alkem Laboratories Limited | 3.89% | up 0.62 pts | ₹53.8 Cr | up ₹11 Cr | Added |
| Indoco Remedies Limited | 3.11% | up 0.32 pts | ₹42.9 Cr | up ₹6.4 Cr | Added |
| Intuitive Surgical Inc | 3.10% | up 0.18 pts | ₹42.8 Cr | up ₹4.6 Cr | Added |
| Dr. Lal Path Labs Limited | 3.06% | up 0.14 pts | ₹42.3 Cr | up ₹4.1 Cr | Added |
| Torrent Pharmaceuticals Limited | 2.98% | up 0.01 pts | ₹41.1 Cr | up ₹2.3 Cr | Added |
| Cash, TREPS & receivables | 2.86% | down 1.77 pts | ₹39.6 Cr | down ₹21.1 Cr | Trimmed |
| Globus Medical Inc | 2.75% | up 0.08 pts | ₹38 Cr | up ₹3 Cr | Added |
| ICICI Lombard General Insurance Company Limited | 2.74% | up 0.02 pts | ₹37.8 Cr | up ₹2.3 Cr | Added |
| Narayana Hrudayalaya Limited | 2.34% | up 0.14 pts | ₹32.4 Cr | up ₹3.5 Cr | Added |
| Abiomed Inc | 2.26% | up 0.15 pts | ₹31.2 Cr | up ₹3.6 Cr | Added |
| JB Chemicals & Pharmaceuticals Limited | 2.04% | down 0.06 pts | ₹28.2 Cr | up ₹72 L | Added |
| Abbott Laboratories | 1.99% | down 0.05 pts | ₹27.5 Cr | up ₹80 L | Added |
| Syngene International Limited | 1.96% | down 0.11 pts | ₹27.1 Cr | down ₹4 L | Held |
| Alembic Pharmaceuticals Limited | 1.58% | down 0.03 pts | ₹21.9 Cr | up ₹74 L | Added |
| Aarti Drugs Limited | 1.56% | down 0.13 pts | ₹21.6 Cr | down ₹61 L | Trimmed |
| Unichem Laboratories Limited | 1.51% | down 0.18 pts | ₹20.9 Cr | down ₹1.3 Cr | Trimmed |
| Kovai Medical Center and Hospital Limited | 0.70% | up 0.18 pts | ₹9.7 Cr | up ₹2.8 Cr | Added |
What changed, May 2021 to Jun 2021
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Sun Pharmaceutical Industries Limitedup ₹15 Cr (+0.63% pts)
- Procter & Gamble Health Limitedup ₹14.2 Cr (+0.76% pts)
- Alkem Laboratories Limitedup ₹11 Cr (+0.62% pts)
- Max Healthcare Institute Limitedup ₹9.9 Cr (+0.44% pts)
- Apollo Hospitals Enterprise Limited
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since May 2021, the weight rose most in Healthcare Services (+1.0 pts) and Healthcare Equipment & Supplies (+0.2 pts), and fell most in Pharmaceuticals & Biotechnology (−1.1 pts).
- Healthcare Services21.1% → 22.2%+1.0 pts
- Healthcare Equipment & Supplies5.9% → 6.0%+0.2 pts
- Pharmaceuticals & Biotechnology63.3% → 62.2%−1.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jun 2020 | Dec 2020 | Mar 2021 | May 2021 | Jun 2021 |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 68.9% | 65.8% | 64.2% | 63.3% | 62.2% |
| Healthcare Services | 16.8% | 20.4% | 22.2% | 21.1% | 22.2% |
| Pharmaceuticals | 10.0% | 6.6% | 7.1% | 6.8% | 6.8% |
| Healthcare Equipment & Supplies | 2.4% | 3.6% | 3.2% | 5.9% | 6.0% |
| Insurance | 1.9% | 3.6% | 3.3% | 2.8% | 2.8% |
Allocation in Jun 2021change vs May 2021
- Pharmaceuticals & Biotechnology (12)62.2%▼ 1.1 pts
- Healthcare Services (7)22.2%▲ 1.0 pts
- Pharmaceuticals (3)6.8%
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Jun 2021
2.9%
▼ 1.8 pts vs May 2021
- Cash alone
- 2.8%
- cash and net receivables
- A year earlier
- 7.6%
- Jun 2020 · now ▼ 4.8 pts
- Last 12 months
- 1.8% – 8.5%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.